Standout Papers
Citation Impact
Citing Papers
Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages
2010 StandoutScience
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
2009
Parkinson disease and incidental Lewy body disease
2015
Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease
2014
Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation
2020
In vivo imaging of hydrogen peroxide production in a murine tumor model with a chemoselective bioluminescent reporter
2010 StandoutNobel
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
2012 StandoutScience
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
2010 StandoutScienceNobel
Parkinson-like syndrome induced by continuous MPTP infusion: Convergent roles of the ubiquitin-proteasome system and α-synuclein
2005 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
The potential prognostic role of cardiovascular autonomic failure in α‐synucleinopathies
2012
Sleep disorders in Parkinson's disease: The contribution of the MPTP non-human primate model
2009
Development of P assive I mmunotherapies for S ynucleinopathies
2015
Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial
2019
The synaptic pathology of α-synuclein aggregation in dementia with Lewy bodies, Parkinson’s disease and Parkinson’s disease dementia
2010
Cerebrovascular disease in ageing and Alzheimer’s disease
2015
Induction of CNS α-synuclein pathology by fibrillar and non-amyloidogenic recombinant α-synuclein
2013
Visual hallucinations in the diagnosis of idiopathic Parkinson's disease: a retrospective autopsy study
2005
Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology
2015
Diagnostic performance of clinical motor and non‐motor tests of Parkinson disease: a matched case–control study
2008
Limelight on Alpha-Synuclein: Pathological and Mechanistic Implications in Neurodegeneration
2013
Chronic Intermittent Hypoxia Alters Local Respiratory Circuit Function at the Level of the preBötzinger Complex
2016
Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis
2014
Apathy in drug-naïve patients with incident Parkinson’s disease: the Norwegian ParkWest study
2009
Cell-based therapies for Parkinson disease—past insights and future potential
2015
Non-motor symptoms of Parkinson's disease: diagnosis and management
2006 Standout
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
2009 Standout
The neuropathological basis for depression in Parkinson's disease
2008
Development of bladder dysfunction in a rat model of dopaminergic brain lesion
2010
Parkinson disease
2017 Standout
Olfaction in Parkinson's disease and related disorders
2011
Pericytes are required for blood–brain barrier integrity during embryogenesis
2010 StandoutNature
Magnetic resonance imaging as a potential biomarker for Parkinson's disease
2015
Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson’s disease
2010
Neuropathology underlying clinical variability in patients with synucleinopathies
2011
Parkinson's disease
2021 Standout
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
2013
Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages
2010
Origins and Effects of Extracellular α-synuclein: Implications in Parkinson’s Disease
2007
Chronic rotenone exposure reproduces Parkinson's disease gastrointestinal neuropathology
2009
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
Pathological roles of α-synuclein in neurological disorders
2011
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Increased dopaminergic cells and protein aggregates in the olfactory bulb of patients with neurodegenerative disorders
2011
Pain in Parkinson's disease and multiple sclerosis: Its relation to the medial and lateral pain systems
2005
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Cutaneous neuropathy in Parkinson’s disease: a window into brain pathology
2014
Impaired Baroreflex Function in Mice Overexpressing Alpha-Synuclein
2013
Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study
2013
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Cerebrospinal fluid biomarkers in Parkinson disease
2013
Hypocretin (orexin) cell loss in Parkinson's disease
2007
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
2005
Loss of γ-Secretase Function Impairs Endocytosis of Lipoprotein Particles and Membrane Cholesterol Homeostasis
2008
Biological and Clinical Implications of Comorbidities in Parkinson’s Disease
2017
Association Between Early-Onset Parkinson Disease and 22q11.2 Deletion Syndrome
2013
Huntington's disease
2007 Standout
Parkinson’s disease: lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons
2007
The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease
2011
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
2010
Pro-resolving lipid mediators are leads for resolution physiology
2014 StandoutNature
Regional differences in the severity of Lewy body pathology across the olfactory cortex
2009
CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ TH-17 cells in relapsing EAE
2007
The Lewy body in Parkinson's disease: Molecules implicated in the formation and degradation of α‐synuclein aggregates
2007
α-Synuclein in the olfactory system of a mouse model of Parkinson’s disease: correlation with olfactory projections
2011
The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease
2017 Standout
The Relationship between Lewy Body Disease, Parkinson's Disease, and Alzheimer's Disease
2003
In vivo neurochemical imaging of olfactory dysfunction in Parkinson’s disease
2012
Constructing and Deconstructing Stem Cell Models of Neurological Disease
2011
Neurochemistry and the non-motor aspects of PD
2011
Relationships between age and late progression of Parkinson's disease: a clinico-pathological study
2010
Toward a redefinition of Parkinson's disease
2012
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases
2013 Nature
Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease
2011
Hypocretin (orexin) loss in Parkinson's disease
2007
Premotor Parkinson's disease: Concepts and definitions
2012
The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease
2011
Association of Olfactory Bulb Volume and Olfactory Sulcus Depth with Olfactory Function in Patients with Parkinson Disease
2011
Widespread and abundant α‐synuclein pathology in a neurologically unimpaired subject
2005
Microglial cell origin and phenotypes in health and disease
2011 Standout
Bladder and bowel dysfunction in Parkinson’s disease
2008
The progression of pathology in Parkinson's disease
2009
Incidental Lewy Body Disease and Preclinical Parkinson Disease
2008
Nonmotor Symptoms of Parkinson's Disease Revealed in an Animal Model with Reduced Monoamine Storage Capacity
2009
Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives
2014
βAPP and Furin mRNA Concentrates in Immature Senile Plaques in the Brain of Alzheimer Patients
2002
The Relationship of Parkinson Disease With Aging
2007
Spreading of pathology in neurodegenerative diseases: a focus on human studies
2015
Alpha-synuclein and transgenic mouse models
2004
Cognitive deficits in a mouse model of pre‐manifest Parkinson’s disease
2012
Inflammatory processes in the aging mouse brain: Participation of dendritic cells and T-cells
2006
Research in motion: the enigma of Parkinson's disease pathology spread
2008
Olfactory testing in parkinsonism
2004
Genetic Animal Models of Parkinson's Disease
2010
Voxel-wise analysis of diffusion weighted imaging reveals disruption of the olfactory tract in Parkinson's disease
2005
Brainstem pathology and non-motor symptoms in PD
2009
Living on the edge with too many mouths to feed: Why dopamine neurons die
2012
Environmental neurotoxic challenge of conditional alpha-synuclein transgenic mice predicts a dopaminergic olfactory-striatal interplay in early PD
2014
Variable phenotype of Alzheimer's disease with spastic paraparesis
2001
Prediagnostic presentations of Parkinson's disease in primary care: a case-control study
2014
Lewy Body Disorders
2017
Rivastigmine for Dementia Associated with Parkinson's Disease
2004
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
2005
Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment
2015
Mice overexpressing wild‐type human alpha‐synuclein display alterations in colonic myenteric ganglia and defecation
2012
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
2011
Development of α-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson’s disease
2007
Presynaptic Mechanisms of l-DOPA-Induced Dyskinesia: The Findings, the Debate, and the Therapeutic Implications
2014
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
2009
Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
2011
Pains in Parkinson disease—many syndromes under one umbrella
2012
Parkinson's disease
2009 Standout
Alpha-synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits
2012
The prion hypothesis in Parkinson's disease: Braak to the future
2013
100 years of Lewy pathology
2012
Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance
2008
Prion-like transmission of protein aggregates in neurodegenerative diseases
2010
Decoding ALS: from genes to mechanism
2016 StandoutNature
Parkin Disease
2013
Analysis of the Adrenal Gland Is Useful for Evaluating Pathology of the Peripheral Autonomic Nervous System in Lewy Body Disease
2007
β-adrenoreceptors and the risk of Parkinson's disease
2020
The Cellular Phase of Alzheimer’s Disease
2016
Abberant α-Synuclein Confers Toxicity to Neurons in Part through Inhibition of Chaperone-Mediated Autophagy
2009
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson’s disease
2008
A clinico-pathological study of subtypes in Parkinson's disease
2009
Late-stage Parkinson disease
2012
Identifying prodromal Parkinson's disease: Pre‐Motor disorders in Parkinson's disease
2012
Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease
2007
Machado-Joseph Disease: from first descriptions to new perspectives
2011
Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein
2012
Regional and progressive changes in brain expression of complexin II in a mouse transgenic for the Huntington’s Disease mutation
2004
Parkinson's disease
2015 Standout
Breaking the chains: structure and function of the deubiquitinases
2009 Standout
Meta‐analysis of early nonmotor features and risk factors for Parkinson disease
2012
Striatal β-Amyloid Deposition in Parkinson Disease With Dementia
2008
Morphogenesis of Lewy Bodies: Dissimilar Incorporation of α-Synuclein, Ubiquitin, and p62
2003
Is alpha‐synuclein in the colon a biomarker for premotor Parkinson's Disease? Evidence from 3 cases
2012
Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies
2013
Ubiquitin–proteasome system and Parkinson's disease
2006
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
2015
α-Synuclein Immunotherapy Blocks Uptake and Templated Propagation of Misfolded α-Synuclein and Neurodegeneration
2014
Frontotemporal lobar degeneration FTLD-tau: preclinical lesions, vascular, and Alzheimer-related co-pathologies
2015
A pathophysiological framework of hippocampal dysfunction in ageing and disease
2011
α-Synuclein Cooperates with CSPα in Preventing Neurodegeneration
2005 StandoutNobel
Parkinson's disease: a dual‐hit hypothesis
2007
Nuclear Receptors, Inflammation, and Neurodegenerative Diseases
2010
The neuropathology of genetic Parkinson's disease
2012
Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model
2004
Differences in expression of junctional adhesion molecule-A and β-catenin in multiple sclerosis brain tissue: increasing evidence for the role of tight junction pathology
2006
Changes in substantia nigra and locus coeruleus in patients with early-stage Parkinson's disease using neuromelanin-sensitive MR imaging
2013
Patterns of levodopa response in Parkinson's disease: a clinico-pathological study
2007
Contribution of cerebrovascular disease in autopsy confirmed neurodegenerative disease cases in the National Alzheimer’s Coordinating Centre
2013
From endoplasmic-reticulum stress to the inflammatory response
2008 StandoutNature
The progression of pathology in longitudinally followed patients with Parkinson’s disease
2008
Biopsies of olfactory epithelium in patients with Parkinson's disease
2009
Novel pharmacological targets for the treatment of Parkinson's disease
2006
Olfaction in Three Genetic and Two MPTP-Induced Parkinson’s Disease Mouse Models
2013
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
2008
Accumulation of Phosphorylated α-Synuclein in Aging Human Brain
2003
Parkinson's disease and α‐synuclein expression
2011
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
2004
Sensory deficit in Parkinson's disease: evidence of a cutaneous denervation
2008
Parkinson's Disease α-Synuclein Transgenic Mice Develop Neuronal Mitochondrial Degeneration and Cell Death
2006
Neurotoxic in vivo models of Parkinson’s disease
2010
Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series
2013
The relevance of iron in the pathogenesis of Parkinson’s disease
2010
Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease
2009
Increased Expression of α-Synuclein Reduces Neurotransmitter Release by Inhibiting Synaptic Vesicle Reclustering after Endocytosis
2010
The interplay of cholinergic function, attention, and falls in Parkinson's disease
2011
The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of α‐synuclein staging
2007
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
2010
Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI
2011
Overview and recent advances in neuropathology. Part 2: Neurodegeneration
2011
Olfaction and Parkinson's syndromes: its role in differential diagnosis
2004
Neuropathologic substrates of Parkinson disease dementia
2012
Model‐guided microarray implicates the retromer complex in Alzheimer's disease
2005
The PtdIns(3,4)P2 phosphatase INPP4A is a suppressor of excitotoxic neuronal death
2010 StandoutNatureNobel
Non-motor features of Parkinson disease
2017 Standout
Genetics of Parkinson's disease
2016
Olfactory deficits in mice overexpressing human wildtype α‐synuclein
2008
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
2011
Molecular and clinical prodrome of Parkinson disease: implications for treatment
2010
Environmental toxins trigger PD-like progression via increased alpha-synuclein release from enteric neurons in mice
2012
The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease
2013
Psychosis, apathy, depression and anxiety in Parkinson's disease
2012
Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease
2008
Glial dysfunction in the pathogenesis of α-synucleinopathies: emerging concepts
2011
Parkinson's Disease and Parkinsonism: Neuropathology
2012
The two-century journey of Parkinson disease research
2017
Linking pathways in the developing and aging brain with neurodegeneration
2014
Glia and alpha-synuclein in neurodegeneration: A complex interaction
2015
Imaging biomarkers in Parkinson's disease
2011
Challenges of modifying disease progression in prediagnostic Parkinson's disease
2016
Neurodegenerative diseases and oxidative stress
2004 Standout
Intragastric proteasome inhibition induces alpha-synuclein-immunopositive aggregations in neurons in the dorsal motor nucleus of the vagus in rats
2006
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model
2012
A cytoarchitectonic and chemoarchitectonic analysis of the dopamine cell groups in the substantia nigra, ventral tegmental area, and retrorubral field in the mouse
2011
Transmission and spreading of tauopathy in transgenic mouse brain
2009
Idiopathic hyposmia as a preclinical sign of Parkinson's disease
2004
Animal models of the non-motor features of Parkinson's disease
2012
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease
2010
α‐Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
2006
Cortical α-synuclein load is associated with amyloid-β plaque burden in a subset of Parkinson’s disease patients
2008
Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system
2012
Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis
2005
Solvent exposures and parkinson disease risk in twins
2011
Non motor subtypes and Parkinson's disease
2015
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
2008
Are synucleinopathies prion-like disorders?
2010
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
2013
The road to restoring neural circuits for the treatment of Alzheimer's disease
2016 Nature
Dementia with Lewy bodies and Parkinson's disease with dementia: Are they different?
2005
Magnetic resonance imaging of the substantia nigra in Parkinson's disease
2012
Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?
2012
Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders
2010
Factors affecting the clinical outcome after neural transplantation in Parkinson's disease
2005
Single-cell transcriptomic analysis of Alzheimer’s disease
2019 StandoutNature
Changes in motor subtype and risk for incident dementia in Parkinson's disease
2006
Pathways towards and away from Alzheimer's disease
2004 StandoutNature
Cognitive dysfunction and depression in Parkinson’s disease: what can be learned from rodent models?
2012
The Neuropathology of Huntington’s Disease
2014
CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain
2008 StandoutNobel
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
2011
Exosomes, an Unmasked Culprit in Neurodegenerative Diseases
2017
Parkinson's disease subtypes: lost in translation?
2012
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
2015
Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding
2007
Best Practices for Generating and Using Alpha-Synuclein Pre-Formed Fibrils to Model Parkinson’s Disease in Rodents
2018
Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP
2010 StandoutNobel
Neuropathology in transplants in Parkinson's disease
2012
Mitochondrial Quality Control and Dynamics in Parkinson's Disease
2011
Expanding Insights on the Involvement of Endoplasmic Reticulum Stress in Parkinson's Disease
2007
Novel nondopaminergic targets for motor features of Parkinson's disease: Review of recent trials
2012
Olfactory dysfunction predicts early transition to a Lewy body disease in idiopathic RBD
2015
Microglial Physiology: Unique Stimuli, Specialized Responses
2009
Risk of Parkinson's disease following anxiety disorders: a nationwide population‐based cohort study
2015
First‐in‐human assessment of PRX002, an anti–α‐synuclein monoclonal antibody, in healthy volunteers
2016
The genetics of P arkinson's disease: Progress and therapeutic implications
2013
EPIDEMIOLOGY OF NEURODEGENERATION
2003
Pain in Parkinson disease: A review of the literature
2012
Preceding pain symptoms and P arkinson's disease: a nationwide population‐based cohort study
2013
The Concept of Prodromal Parkinson’s Disease
2015
Accuracy of clinical diagnosis of Parkinson disease
2016
The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics
2002 StandoutScience
Alimentary, my dear Watson? The challenges of enteric α‐synuclein as a Parkinson's disease biomarker
2013
Genetic mouse models of Parkinson’s disease
2010
Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
2015
Diagnosis and Treatment of Parkinson Disease
2020 Standout
The neurobiological basis of cognitive impairment in Parkinson's disease
2014
Multiple organ involvement by alpha‐synuclein pathology in Lewy body disorders
2014
Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits
2003
Stage‐dependent nigral neuronal loss in incidental Lewy body and Parkinson's disease
2014
A Century of Alzheimer's Disease
2006 StandoutScience
Systemic exosomal siRNA delivery reduced alpha‐synuclein aggregates in brains of transgenic mice
2014
Fatigue in levodopa-naive subjects with Parkinson disease
2008
Ion-dependent protein–surface interactions from intrinsic solvent response
2021 StandoutNobel
Intracerebral inoculation of pathological α-synuclein initiates a rapidly progressive neurodegenerative α-synucleinopathy in mice
2012
Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative Diseases
2015
Enteric alpha‐synuclein expression is increased in P arkinson's disease but not A lzheimer's disease
2013
Calcium, Bioenergetics, and Neuronal Vulnerability in Parkinson's Disease
2012
Evolution of prodromal Parkinson’s disease and dementia with Lewy bodies: a prospective study
2019
Nonmotor features of Parkinson's disease subtypes
2016
Evolution of Prodromal Clinical Markers of Parkinson Disease in aGBAMutation–Positive Cohort
2014
Neuropathology of prodromal Lewy body disease
2014
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Small molecule probes to quantify the functional fraction of a specific protein in a cell with minimal folding equilibrium shifts
2014 StandoutNobel
Health‐related quality of life in early Parkinson's disease: The impact of nonmotor symptoms
2013
Inositol hexakisphosphate suppresses excitatory neurotransmission via synaptotagmin-1 C2B domain in the hippocampal neuron
2012 StandoutNobel
Retinopathy in Parkinson disease
2009
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
Lewy body extracts from Parkinson disease brains trigger α‐synuclein pathology and neurodegeneration in mice and monkeys
2013
Prodromal features for P arkinson's disease – baseline data from the TREND study
2014
Imaging prodromal Parkinson disease
2014
Complementary roles of gasotransmitters CO and H2S in sleep apnea
2017 StandoutNobel
Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease
2019
Review: The future of cell therapies and brain repair: P arkinson's disease leads the way
2013
Amyloid precursor protein (APP) traffics from the cell surface via endosomes for amyloid β (Aβ) production in the trans -Golgi network
2012 StandoutNobel
Mutual exacerbation of peroxisome proliferator‐activated receptor γ coactivator 1α deregulation and α‐synuclein oligomerization
2014
Exosomes as drug delivery vehicles for Parkinson's disease therapy
2015 Standout
Sleep Dysfunction and EEG Alterations in Mice Overexpressing Alpha-Synuclein
2018
Apolipoprotein E ε4 allele, AD pathology, and the clinical expression of Alzheimer’s disease
2003
Neurons generated by direct conversion of fibroblasts reproduce synaptic phenotype caused by autism-associated neuroligin-3 mutation
2013 StandoutNobel
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
2007 StandoutScience
Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD
2005
Stress-Activated Cap'n'collar Transcription Factors in Aging and Human Disease
2010
Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease
2009
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
2011 StandoutNobel
Resolution of inflammation is altered in Alzheimer's disease
2014
In vivo gastric detection of α‐synuclein inclusions in Parkinson's disease
2014
How pain arises in P arkinson's disease?
2013
Cardiovascular Autonomic Dysfunction in Animal Models of Parkinson's Disease
2011
α‐Synuclein pathology does not predict extrapyramidal symptoms or dementia
2004
Self-catalyzed growth of S layers via an amorphous-to-crystalline transition limited by folding kinetics
2010 StandoutNobel
Real-time imaging of Huntingtin aggregates diverting target search and gene transcription
2016 Nobel
Alzheimer’s and Parkinson’s diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein
2015 Science
Reduced Vascular Endothelial Growth Factor and Capillary Density in the Occipital Cortex in Dementia with L ewy Bodies
2014
Differences in neuropathologic characteristics across the Lewy body dementia spectrum
2006
Liquid phase condensation in cell physiology and disease
2017 StandoutScience
Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings
2015
Are Major Dementias Triggered by Poor Blood Flow to the Brain? Theoretical Considerations
2017
α‐Synuclein oligomers and clinical implications for Parkinson disease
2012
Works of Udo Rüb being referenced
The Brainstem Pathologies of Parkinson's Disease and Dementia with Lewy Bodies
2014
Apolipoprotein E co-localizes with newly formed amyloid β-protein (Aβ) deposits lacking immunoreactivity against N-terminal epitopes of Aβ in a genotype-dependent manner
2005
Cognitive function in multiple system atrophy of the cerebellar type
2006
Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered
2006
Staging of brain pathology related to sporadic Parkinson’s disease
2002 Standout
Stages in the development of Parkinson’s disease-related pathology
2004 Standout
The intralaminar nuclei assigned to the medial pain system and other components of this system are early and progressively affected by the Alzheimer's disease-related cytoskeletal pathology
2002
Cognitive status correlates with neuropathologic stage in Parkinson disease
2005
Involvement of precerebellar nuclei in multiple system atrophy
2003
α-Synuclein immunopositive Parkinson's disease-related inclusion bodies in lower brain stem nuclei
2001
Sequence of Aβ-Protein Deposition in the Human Medial Temporal Lobe
2000
Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease
1999
Inverse Relationship Between Cerebrovascular Lesions and Severity of Lewy Body Pathology in Patients With Lewy Body Diseases
2010
Spinocerebellar Ataxia Type 3 (SCA3): Thalamic Neurodegeneration Occurs Independently from Thalamic Ataxin‐3 Immunopositive Neuronal Intranuclear Inclusions
2006
Pathology associated with sporadic Parkinson’s disease — where does it end?
2006
Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system
2000
Alzheimer-Related τ-Pathology in the Perforant Path Target Zone and in the Hippocampal Stratum Oriens and Radiatum Correlates with Onset and Degree of Dementia
2000
The nucleus raphe interpositus in spinocerebellar ataxia type 3 (Machado–Joseph disease)
2003
Parkinson’s disease: the thalamic components of the limbic loop are severely impaired by α-synuclein immunopositive inclusion body pathology
2002
Where Does Parkinson Disease Pathology Begin in the Brain?
2002
New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado–Joseph disease)
2008
Cognitive decline correlates with neuropathological stage in Parkinson's disease
2006
Neuroanatomical characteristics of the human pre-Bötzinger complex and its involvement in neurodegenerative brainstem diseases
2010
Relationship of Apolipoprotein E and Age at Onset to Parkinson Disease Neuropathology
2006
Two Types of Sporadic Cerebral Amyloid Angiopathy
2002
SCA3: Neurological features, pathogenesis and animal models
2008
Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington’s disease
1996
First appraisal of brain pathology owing to A30P mutant alpha‐synuclein
2010
Gender and age modify the association between APOE and AD-related neuropathology
2001
Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)
2002
Errata
2010
Spinocerebellar ataxia type 3 (Machado-Joseph disease): severe destruction of the lateral reticular nucleus
2002
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
2002 Standout
Degeneration of the Cerebellum in H untington's Disease (HD ): Possible Relevance for the Clinical Picture and Potential Gateway to Pathological Mechanisms of the Disease Process
2012